We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.



Matts Johansen

Chief Executive Officer (CEO)

Matts joined Aker BioMarine in 2009. Before being named the CEO in 2015, Matts was the Chief Operating Officer of Aker BioMarine. As the CEO of Aker BioMarine, Matts is on a mission to improve human and planetary health. Prior to joining Aker BioMarine, he was the Chief Marketing Officer at Telefonica O2. Before thatMatts studied at Oslo University College and Columbia University.

As of December 3, 2021, Matts Johansen owns 1,040,714 Shares through his wholly owned company KMMN Invest II AS (representing approximately 1.05% of the Shares in the Company). Johansen has no share options.

Matts is temporarily heading the Human Health and Nutrition segment. 

Click image to download.

Katrine Klaveness

Chief Financial Officer (CFO)

Katrine is the CFO of Aker BioMarine, responsible for the company’s Finance and Accounting function, overseeing treasury, tax, legal, accounting and business intelligence. She joined Aker BioMarine from Yara where she was CFO for the Production segment, and prior to that she spent more than 10 years in the Aker system in different senior corporate financial positions, including Aker ASA and Aker BP (formerly Det norske oljeselskap ASA). Katrine spent her first years in McKinsey & Company, and holds a Master’s from BI, the Norwegian Business School.

As of April 13, 2021, Klaveness currently owns 4,450 shares in the company and has no share options.


Click image to download.

Tone Lorentzen

EVP Supply Chain

Tone joined Aker BioMarine in 2015.
She oversees Aker BioMarine’s entire supply
chain, including global logistics, customer care, production at the krill oil factory in Houston, third-party production, warehouses, product quality, Quality Assurance and HSSE.

Tone has 25 years of experience with global supply chain operations. Prior to joining Aker BioMarine, Tone has worked at Nycomed, Amersham, GE Healthcare and Trygg Pharma.

As of April 13, 2021, Lorentzen currently owns 4,500 shares in the company and has no share options.

Click image to download.

Shauna Cecilia McNeill

EVP Innovation

Shauna has been with Aker BioMarine since 2017. She is responsible for the company’s new and on-going programs to research, develop and commercialize krill derived products and applications. Shauna has worked in a variety of strategy, product and business development roles including at Ecolab and the Boston Consulting Group. Shauna holds both an MBA from Harvard Business School and a B.S. in Chemical Engineering from the University of Minnesota.

As of April 13, 2021, McNeill currently owns 4,870 shares in the company and has no share options.


Click image to download.

Sigve Nordrum

EVP Animal Health and Nutrition

Sigve has been with Aker BioMarine since 2007. He is responsible for the sales, marketing and R&D for krill products for the animal and aquaculture markets globally. Prior to joining the company, Sigve worked at BioMar and the Norwegian Ministry of Fisheries. Sigve has a Master’s degree from the Norwegian School of Life Sciences and a PhD from the Norwegian Veterinary College.

As of April 13, 2021, Nordrum currently owns 5,000 shares in the company and has no share options.


Click image to download.

Todd Norton

EVP Special Advisor

Todd has been with Aker BioMarine since 2010. He is responsible for strategic initiatives, as well as the company's operations in the U.S. Prior to joining Aker BioMarine, Todd was the President and COO at Sabinsa. He also has more than 40 years’ experience working in the nutraceutical industry. Todd has a B.A. degree in Business Management.

Horton had no company shares or share options as of April 13, 2021.


Click image to download.

Trond Atle Smedsrud

EVP Strategic Investments

Trond Atle joined Aker BioMarine in 2015 and previously ran Aker BioMarine’s Marketing and Innovation department. In order to secure future relevance and financial growth for the company, in his current role Trond Atle is responsible for exploring, securing and growing new corporate investments. Prior to joining Aker BioMarine, Trond Atle worked in senior positions at Coca-Cola and PwC. Trond Atle has a Master’s degree from BI Norwegian School of Management.

As of April 13, 2021, Trond Atle Smedsrud owns 4,800 Shares through his wholly-owned investment company Hawi Holding AS. Smedsrud has no share options.


Click image to download.

Hege Spaun

Chief Officer People & External Affairs

Hege joined Aker BioMarine in 2016.  She is responsible for increasing Aker BioMarine's transparency, connecting the day-to-day operations with the company's strategy and transforming the business to meet increasing expectations from customers, employees and other stakeholders. Prior to joining Aker BioMarine, Hege was a Senior consultant for organizational development at DNV GL. Hege has a Master’s degree in Psychology from the University of Oslo.

As of September 28, 2021, Spaun currently owns 2,235 shares in the company and has no share options.


Click image to download.

Webjørn Barstad

EVP Offshore

A self-described ‘boat guy’, Webjørn Barstad has jumped on board a new mission as Executive Vice President, responsible for Aker BioMarine’s offshore krill harvesting operations. Barstad has spent his entire career within the seafood industry, most recently serving as the CEO for Lerøy Havfisk (ocean fisheries) and Lerøy Norway Seafoods (shorebased processing), and COO at Lerøy Seafood Group. Webjørn has an MSC in International Banking and Financial Studies from Heriot-Watt University Business School, Edinburgh.

As of September 2o, 2021, Barstad currently owns 12,000 shares in the company and has no share options.


Click image to download.



Superba Krill™ oil is extracted from the Antarctic krill species Euphausia Superba. Krill are small shrimp-like crustaceans packed full of health promoting long-chain omega-3 fatty acids (EPA & DHA), phospholipids, choline and astaxanthin.